Market Cap 50.41M
Revenue (ttm) 0.00
Net Income (ttm) -23.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 288,000
Avg Vol 301,810
Day's Range N/A - N/A
Shares Out 86.42M
Stochastic %K 20%
Beta 1.07
Analysts Strong Sell
Price Target $3.78

Latest News on ONCY

Oncolytics Biotech Inc. (ONCY) Q4 2024 Earnings Call Transcript

Mar 7, 2025, 11:11 AM EST - 7 weeks ago

Oncolytics Biotech Inc. (ONCY) Q4 2024 Earnings Call Transcript


Oncolytics Biotech Inc. (ONCY) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 9:01 PM EST - 5 months ago

Oncolytics Biotech Inc. (ONCY) Q3 2024 Earnings Call Transcript


Oncolytics Biotech Inc. (ONCY) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 7:55 PM EDT - 9 months ago

Oncolytics Biotech Inc. (ONCY) Q2 2024 Earnings Call Transcript